AstraZeneca's Seroquel XR gets US FDA nod for bipolar disorder
Monday, October 13, 2008 09:00 IST United Kingdom
AstraZeneca announced that the US Food and Drug Administration (FDA) has approved once-daily Seroquel XR (quetiapine fumarate) Extended-Release tablets for the acute treatment of the depressive episodes